Long-term Survival after Carotid Endarterectomy in a Population with a Low Coronary Heart Disease Fatality:

Carlos Ruiz-Carmona1, Carles Diaz-Duran1, Nerea Sevilla1

  • 1Angiology and Vascular Surgery Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.

Insights

Long-term survival after carotid endarterectomy (CEA) in a Mediterranean population was assessed. Cancer was the leading cause of death, and survival rates were at the lower range observed in other studies.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Medicine
  • Oncology

Background:

  • Long-term survival is crucial for managing severe asymptomatic carotid stenosis.
  • Limited data exist for populations with low coronary heart disease incidence.
  • This study evaluates long-term survival post-carotid endarterectomy (CEA) in a Mediterranean setting.

Purpose of the Study:

  • To assess long-term survival rates following CEA.
  • To identify risk factors associated with long-term survival after CEA.
  • To understand the influence of regional characteristics on survival outcomes.

Main Methods:

  • Retrospective analysis of 291 patients undergoing CEA (2005-2014).
  • Kaplan-Meier life table analysis and multivariable Cox regression were employed.
  • Risk factors for long-term survival were analyzed.

Main Results:

  • Immediate combined mortality/morbidity was 2.7%.
  • Mean follow-up was 55 months; 21.3% of patients died, with cancer being the most frequent cause (35.5%).
  • Independent survival predictors included age, ASA class IV, and preoperative hemoglobin. 3- and 5-year survival rates were 89% and 81%.

Conclusions:

  • Long-term survival in this CEA cohort was at the lower end of reported ranges.
  • Cancer significantly impacted long-term survival.
  • Predictive survival models may be influenced by regional factors.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567